ENTITY
Eisai Co Ltd

Eisai Co Ltd (4523 JP)

103
Analysis
Health CareJapan
Eisai Co., Ltd. produces prescription drugs and medical equipment and sells mainly to sales agents and subsidiaries. Through its subsidiary, Sanko Junyaku, the Company produces and sells diagnostic drugs. Eisai also markets its products through related companies in the US, Europe, and Asia. The Company also manufactures and sells foods, livestock feeds, chemical, and agrochemicals.
more
Refresh
06 Apr 2018 13:44

Japan Pharma: Upcoming Catalysts & Event Driven Trading Ideas

Takeda Pharmaceutical Co Ltd (4502 JP), Shionogi & Co Ltd (4507 JP), Nippon Shinyaku Co Ltd (4516 JP) , Sumitomo Dainippon Pharma Co (4506 JP),...

05 Apr 2018 19:21

Symbio Pharma (4582 JP) - Gross Margin Expansion Led Operational Turnaround in 2021

2020 – an inflection point for Symbio Treakisym (bendamustine), Symbio’s only revenue driver currently, is marketed by Eisai in Japan for r/r NHL....

29 Mar 2018 14:03

Japan Pharmaceutical - Sector Overview

Core coverage – relative valuations Takeda Pharmaceutical Co Ltd (4502 JP) (NB: Pre-Shire announcement | Pro-Forma analysis to be published...

23 Feb 2018 08:47

Which Names Are the Japanese Brokers More Bullish / Bearish On....

We isolated the Japanese brokers to see if there was a significant difference between the Japanese broker outlook and Foreign outlook. We compared...

Logo
165 Views
Share
16 Nov 2017 06:26

Names Down in the First 11 Months Tend to Go up in Japan.....

We looked back over the last 16 years and found that names that are down in the first 11 months tend to outperform in December. To calculate the...

Logo
258 Views
Share
x